Certified by Founder
Lodge
Santa Ana Bio, Inc.
start up
United States
- Alameda, California
- 14/06/2024
- Series A
- $168,000,000
Santa Ana Bio is a Bay Area biotech focused on leveraging it’s multiomics and protein engineering platforms to design precision biologics for the treatment of patients with serious immune related diseases.
- Industry Biotechnology Research
- Website https://www.santaanabio.com/
- LinkedIn https://www.linkedin.com/company/santaanabio/
Sycamore Labs | $65,000,000 | (Mar 31, 2026)
Deccan AI | $25,000,000 | (Mar 31, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)
OpenBox AI | $5,000,000 | (Mar 31, 2026)
Qodo | $70,000,000 | (Mar 31, 2026)
Starcloud | $170,000,000 | (Mar 31, 2026)
Valinor(1) | $25,000,000 | (Mar 31, 2026)
Mars Men | $27,500,000 | (Mar 31, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)